Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (10): 829-833    DOI: 10.19485/j.cnki.issn2096-5087.2023.10.001
  论著 本期目录 | 过刊浏览 | 高级检索 |
孕前体质指数与妊娠糖尿病的剂量-反应关系
李娜娜1, 张师静1, 陈巧敏1, 栗浩然2, 王雅莉2
1.郑州大学附属郑州中心医院营养科,河南 郑州 450007;
2.郑州大学附属郑州中心医院,河南 郑州 450007
Dose-response relationship between pre-pregnancy body mass index and gestational diabetes mellitus
LI Nana1, ZHANG Shijing1, CHEN Qiaomin1, LI Haoran2, WANG Yali2
1. Department of Nutrition, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, China;
2. Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, China
全文: PDF(1088 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析孕前体质指数(BMI)与妊娠糖尿病(GDM)的剂量-反应关系,为制定合理的孕前BMI控制目标,优化GDM防控策略提供依据。方法 选择2021年郑州市中心医院入院登记的孕产妇为研究对象,收集人口学资料、家族史、孕产史和孕期血糖监测资料。建立限制性立方样条回归模型分析孕前BMI与GDM的剂量-反应关系,采用受试者操作特征曲线(ROC曲线)评价孕前BMI预测GDM发病的能力。结果 纳入2 279名孕产妇。年龄MQR)为29.0(5.0)岁。孕前BMI MQR)为21.1(3.8)kg/m2;其中,体重过轻312人,占13.69%;低正常体重825人,占36.20%;高正常体重730人,占32.03%;超重345例,占15.14%;肥胖67例,占2.94%。GDM患病392例,患病率为17.20%。限制性立方样条回归模型分析结果显示,孕前BMI、年龄与GDM呈线性剂量-反应关系,孕前BMI>21.1 kg/m2时,GDM发病风险随孕前BMI的增加而升高;年龄>29.0岁时GDM发病风险随年龄的增加而升高;>29.0岁组孕前BMI所致GDM发病风险的剂量-反应关系强度普遍高于≤29.0岁组(均P<0.05)。孕前BMI预测GDM发病风险的ROC曲线下面积为0.654(95%CI:0.624~0.684);孕前BMI以24.0 kg/m2为界值时,约登指数、灵敏度和特异度分别为0.238、0.472和0.766;孕前BMI以23.0 kg/m2为界值时,约登指数、灵敏度和特异度分别为0.195、0.342和0.853;孕前BMI以21.1 kg/m2为预警值时,约登指数、灵敏度和特异度分别为0.213、0.676和0.537。结论 孕前BMI与GDM呈线性剂量-反应关系,孕前BMI>21.1 kg/m2可增加GDM发病风险。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李娜娜
张师静
陈巧敏
栗浩然
王雅莉
关键词 妊娠糖尿病孕前体质指数年龄剂量-反应关系    
AbstractObjective To explore the dose-response relationship between pre-pregnancy body mass index (BMI) and gestational diabetes mellitus (GDM), so as to provide insights into the cut-off values of pre-pregnancy BMI and optimizing GDM prevention and control strategies. Methods Pregnant women that admitted to Zhengzhou Central hospital in 2021 were recruited, and demographics, family history, pregnancy and delivery history and blood glucose levels during pregnancy were collected. The dose-response relationship between pre-pregnancy BMI and GDM was analyzed using restricted cubic spline (RCS) analysis. The predictive ability of pre-pregnancy BMI for GDM risk was evaluated using receiver operating characteristic (ROC) curve. Results A total of 2 279 participants were included in the study. The median age was 29.0 (interquartile range, 5.0) years. The median pre-pregnancy BMI was 21.1 (interquartile range, 3.8) kg/m2. There were 312 underweight women (13.69%), 825 women with low-normal weight (36.20%), 730 women with high-normal weight (32.03%), 345 overweight women (15.14%) and 67 obese women (2.94%).The prevalence of GDM was 17.20%. RCS analysis suggested a linear dose-response relationship between age, pre-pregnancy BMI and GDM (P<0.05). When pre-pregnancy BMI was higher than 21.1 kg/m2, the risk of GDM increased with pre-pregnancy BMI (P<0.05). When women aged over 29.0 years, the risk of GDM increased with age, and the dose-response relationship of GDM caused by pre-pregnancy BMI was stronger in the women aged over 29.0 years than in the women aged 29.0 years and below (P<0.05). The area under curve (AUC) was 0.654 (95%CI: 0.624-0.684). If the cut-off value of pre-pregnancy BMI was 23.0 kg/m2, the Youden index, sensitivity and specificity was 0.238, 0.472 and 0.766, respectively. If it was 24.0 kg/m2, the Youden index, sensitivity and specificity was 0.195, 0.342 and 0.853, respectively. If it was 21.1 kg/m2, the Youden index, sensitivity and specificity was 0.213, 0.676 and 0.537, respectively. Conclusion There is a linear dose-response relationship between pre-pregnancy BMI and GDM, and higher than 21.1 kg/m2 of the pre-pregnancy BMI could increase the risk of GDM.
Key wordsgestational diabetes mellitus    pre-pregnancy body mass index    age    dose-response relationship
收稿日期: 2023-04-25      修回日期: 2023-07-05      出版日期: 2023-10-10
中图分类号:  R714.25  
基金资助:河南省医学科技攻关计划联合共建项目(LHGJ20220863)
作者简介: 李娜娜,硕士,主管医师,主要从事营养工作
引用本文:   
李娜娜, 张师静, 陈巧敏, 栗浩然, 王雅莉. 孕前体质指数与妊娠糖尿病的剂量-反应关系[J]. 预防医学, 2023, 35(10): 829-833.
LI Nana, ZHANG Shijing, CHEN Qiaomin, LI Haoran, WANG Yali. Dose-response relationship between pre-pregnancy body mass index and gestational diabetes mellitus. Preventive Medicine, 2023, 35(10): 829-833.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.10.001      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I10/829
[1] GUARIGUATA L,LINNENKAMP U,BEAGLEY J,et al.Global estimates of the prevalence of hyperglycaemia in pregnancy[J]. Diabetes Res Clin Pr,2014,103(2):176-185.
[2] 娜仁其木格,李冬梅,米林香,等.中国妊娠期糖尿病患病率的Meta分析[J].中国循证医学杂志,2018,18(3):280-285.
[3] STROBEL K M,KAFALI S G,SHIH S,et al.Pregnancies complicated by gestational diabetes and fetal growth restriction:an analysis of maternal and fetal body composition using magnetic resonance imaging[J]. J Perinatol,2023,43(1):44-51.
[4] JOHNS E C,DENISON F C,NORMAN J E,et al.Gestational diabetes mellitus: mechanisms,treatment,and complications[J]. Trends Endocrinol Metab,2018,29(11):743-754.
[5] LEE S M,SHIVAKUMAR M,PARK J W,et al.Long-term cardiovascular outcomes of gestational diabetes mellitus:a prospective UK Biobank study[J]. Cardiovasc Diabetol,2022,21(1):221-234.
[6] NAJAFI F,HASANI J,IZADI N,et al.Risk of gestational diabetes mellitus by pre-pregnancy body mass index:a systematic review and meta-analysis[J/OL]. Diabetes Metab Syndr,2021,15(4)[2023-07-05].https://doi.org/10.1016/j.dsx.2021.06.018.
[7] TORLONI M R,BETRÁN A P,HORTA B L,et al. Prepregnancy BMI and the risk of gestational diabetes:a systematic review of the literature with meta-analysis[J]. Obes Rev,2009,10(2):194-203.
[8] MORISSET A S,ST-YVES A,VEILLETTE J,et al.Prevention of gestational diabetes mellitus:a review of studies on weight management[J]. Diabetes Metab Res Rev,2010,26(1):17-25.
[9] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
[10] BLACK M H,SACKS D A,XIANG A H,et al.The relative contribution of prepregnancy overweight and obesity,gestational weight gain,and IADPSG-defined gestational diabetes mellitus to fetal overgrowth[J]. Diabetes Care,2013,36(1):56-62.
[11] World Health Organization.Diet,nutrition and the prevention of chronic diseases report of the joint WHO/FAO expert consultation[EB/OL].[2023-07-05].http://www.who.int/dietphysicalactivity/publications/trs916/download/en.
[12] NAKANISHI K,SAIJO Y,YOSHIOKA E,et al.Severity of low pre-pregnancy body mass index and perinatal outcomes:the Japan Environment and Children's Study[J]. BMC Pregnancy Childb,2022,22(1):121-130.
[13] TEUFEL F,SEIGLIE J A,GELDSETZER P,et al.Body-mass index and diabetes risk in 57 low-income and middle-income countries:a cross-sectional study of nationally representative,individual-level data in 685 616 adults[J]. Lancet,2021,398(10296):238-248.
[14] CHENG P J,DUAN T.China's new two child policy:maternity care in the new multiparous era[J]. BJOG,2016,123(Suppl.3):7-9.
[15] 任艳军,刘庆敏,刘冰,等. 2009—2018年杭州市妊娠糖尿病发病趋势[J]. 预防医学,2020,32(3):244-247.
[16] LI Y Y,REN X H,HE L L,et al.Maternal age and the risk of gestational diabetes mellitus:a systematic review and meta-analysis of over 120 million participants[J/OL].Diabetes Res Clin Pr,2020,162[2023-07-05].https://doi.org/10.1016/j.diabres.2020.108044.
[17] 王丽君,甘培元,何丽雅,等.妊娠中期糖脂代谢水平与妊娠结局的相关性分析[J].预防医学,2018,30(8):762-765,770.
[18] MANDÒ C,ABATI S,ANELLI G M,et al.Epigenetic profiling in the saliva of obese pregnant women[J/OL].Nutrients,2022,14(10)[2023-07-05].https://doi.org/10.3390/nu14102122.
[19] SUN M T,LUO M J,WANG T T,et al.Effect of the interaction between advanced maternal age and pre-pregnancy BMI on pre-eclampsia and GDM in Central China[J/OL].BMJ Open Diabetes Res Care,2023,11(2)[2023-07-05].http://dx.doi.org/10.1136/bmjdrc-2023-003324.
[1] 郑伟, 张世勇, 杨纶砥, 熊华利. 基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J]. 预防医学, 2023, 35(8): 665-668,681.
[2] 马奕竹, 赵效国, 朱启英, 马依拉·买买提, 张环美, 苑晓琳, 李莉. 孕期膳食模式与妊娠糖尿病的关联研究[J]. 预防医学, 2023, 35(4): 286-290.
[3] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[4] 刘锐, 蔺茂文, 江鸿, 李舒超, 张凡, 孙春. 2008—2022年荆州市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J]. 预防医学, 2023, 35(10): 871-876.
[5] 郑云枝, 侯灿灿, 曹锦程, 崔总文, 王茂, 崔俊鹏. 心肺适能与心脑血管疾病发病关系的Meta分析[J]. 预防医学, 2022, 34(3): 282-288,293.
[6] 舒铭铭, 潘兴强, 张百蕾, 黄芳, 张婧, 洪菱, 蔡婕. 被动吸烟与妊娠糖尿病的关联分析[J]. 预防医学, 2020, 32(7): 726-729.
[7] 陈晓雯, 胡文胜, 朱旭红, 姜李媛, 陈亚. 孕前体质指数、孕期增重对巨大儿发生的影响[J]. 预防医学, 2020, 32(4): 414-417.
[8] 任艳军, 刘庆敏, 刘冰, 张艳, 赵刚, 丁华. 2009—2018年杭州市妊娠糖尿病发病趋势[J]. 预防医学, 2020, 32(3): 244-247.
[9] 陈冬琳, 徐键. 同型半胱氨酸与妊娠相关疾病研究进展[J]. 预防医学, 2020, 32(2): 147-151.
[10] 陈颖, 陈莉莉, 徐晓红, 黄珍珍, 娄增谦. 丽水市孕妇血清维生素水平分析[J]. 预防医学, 2020, 32(2): 184-186.
[11] 史美琦, 郑钜圣, 付元庆, 卢莎, 汪旭虹, 胡文胜. 妊娠糖尿病孕妇血清25-(OH)D水平与代谢性指标的相关性研究[J]. 预防医学, 2020, 32(10): 1069-1071.
[12] 曾召琼, 李萍, 谭凌卉, 易帆, 谢小兵. 长沙市女性HPV高危基因型及年龄分布特征分析[J]. 预防医学, 2020, 32(1): 91-93.
[13] 张芝银, 李秀央, 郑国英, 黄晶, 周红. 不良妊娠结局的影响因素分析[J]. 预防医学, 2020, 32(1): 94-97.
[14] 张妍, 金亚清, 于宏杰, 袁红. 嘉定区出生监测结果分析[J]. 预防医学, 2019, 31(12): 1269-1272.
[15] 王丽君, 甘培元, 何丽雅, 陆怡, 何文芳, 徐泽汝, 郭君平, 华燕吟. 妊娠中期糖脂代谢水平与妊娠结局的相关性分析[J]. 预防医学, 2018, 30(8): 762-765,770.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed